A panel of life science experts recently debated the challenges and opportunities for emerging life science businesses in the current environment.
It was part of the launch of the UK Life Science Start-up Report 2010: the first in-depth review of the state of the life science start-up sector in the UK. The report looks at where and what type of companies are being formed, where the investment is going, and the varied role universities are playing.
The panel members were:
The Mobius Life Sciences Fund, a new investment fund focused on providing seed finance for life science companies, is officially launched on Thursday 1st October 2009.
The Mobius Life Sciences Fund is designed to fill the considerable gap in early- stage venture funding for a sector which is notoriously high risk and money- intensive. At a time when many private venture funds shy from seed funding in this area, the Mobius Life Sciences Fund will provide the crucial bridge in finance and expertise which will enable these supported companies to succeed in subsequent funding rounds.
The new private venture fund has been made possible by the continuing success of BioCity Nottingham, one of Europe’s fastest growing bioscience and life sciences incubators. Mobius Life Sciences funds are securely generated through the incubator’s internal operating activity. In addition, Mobius Life Sciences Fund has won the support of Nottingham City Council in the provision of unsecured loan finance alongside the Mobius equity investment.